MCR Live

2018/11/28

Rattler Publishing: The 2018 Rattler Publishing, Gemini, and Shunya Su...

Rattler Publishing: The 2018 Rattler Publishing, Gemini, and Shunya Su...: Midway through the Rattler Publishing, Gemini, Shunya Summit here in Montreal Canada The CEO of Rattler Publishing takes a rest before takin...

1 comment:

  1. How is this drug being sold in Trinidad & Tobago even though it was not approved by the FDA with such dangerous side effects? We need answers!
    Arcoxia
    Generic Name: etoricoxib
    Note: Arcoxia has not been approved by the FDA for the U.S. market. The manufacturer of Arcoxia received a non-approvalable letter from the FDA in April of 2007. This non-approvable letter was due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) and questions on the benefit-risk ratio in patients taking Arcoxia. Merck will continue to market Arcoxia outside the United States.

    ReplyDelete

2020 on the Rattler Publishing Floor

This Saturday meeting brought MCR too the next evolutionary phase of it's existence. The command staff is tightening the policy of oper...